Economics of Glaucoma Care

Glaucoma is a growing and costly disease. Modeling suggests treatment of glaucoma is cost-effective, but more research is needed to establish which populations stand to benefit the most from different courses of treatment.With looming changes in healthcare coverage, it will be incumbent upon providers and researchers to develop analyses, employ rigorous methodologies and advocate for accurate analyses. Without evidence and advocacy, resources may be misdirected and patients will have higher rates of vision loss or disability.

Duke Scholars

Author Paul Pue-Jung Lee Ophthalmology, Glaucoma